Stereotactic transplantation of a dopamine-producing capsule into the striatum for treatment of Parkinson disease: A preclinical primate study

Journal of Neurosurgery

Volumn 98, Issue 4, 2003, Pages 874-881

  Yoshida, Hideyuki ^a   Date, Isao ^a   Shingo, Tetsuro ^a   Fujiwara, Kenjiro ^a   Kobayashi, Kazuki ^a   Miyoshi, Yasuyuki ^a   Ohmoto, Takashi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Macaca fuscata; Neural transplantation; Nonhuman primate; Parkinson disease; PC12 cell

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; DOPAMINE; LEVODOPA;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ENCAPSULATION; CELL STRAIN; DEGENERATIVE DISEASE; DRUG DELIVERY SYSTEM; ELECTROCHEMICAL DETECTION; FETAL TISSUE TRANSPLANTATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOLOGY; IMPLANTATION; MONKEY; NEUROLOGIC DISEASE; NEUROSURGERY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PRIMATE; PRIORITY JOURNAL; STEREOTAXIC SURGERY;

EID: 0037385053     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.2003.98.4.0874     Document Type: Article

References (35)

1. Abercrombie M: Estimation of nuclear population from microtome sections. Anat Rec 94:239-247, 1946
2. Aebischer P, Goddard M, Signore AP, et al: Functional recovery in hemiparkinsonian primates transplanted with polymer-encapsulated PC12 cells. Exp Neurol 126:151-158, 1994
3. Aebischer P, Pochon NAM, Heyd B, et al: Gene therapy for amyotrophic lateral sclerosis (ALS) using a polymer encapsulated xenogenic cell line engineered to secrete hCNTF. Hum Gene Ther 7:851-860 1996
4. Aebischer P, Schluep M, Deglon N, et al: Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients. Nat Med 2:696-699, 1996
5. Aebischer P, Tresco PA, Winn SR, et al: Long-term cross-species brain transplantation of a polymer-encapsulated dopamine-secreting cell line. Exp Neurol 111:269-275, 1991
6. Bing GY, Notter MFD, Hansen JT, et al: Comparison of adrenal medullary, carotid body and PC12 cell grafts in 6-OHDA lesioned rat. Brain Res Bull 20:399-406, 1988
7. Cheng L, Allore RJ, Richardson PM: Entry of monocytes into the brain after injection of Corynebacterium parvum. Exp Neurol 149:322-328, 1998
8. Date I, Ohmoto T, Imaoka T, et al: Cografting with polymer-encapsulated human nerve growth factor-secreting cells and chromaffin cell survival and behavioral recovery in hemiparkinsonian rats. J Neurosurg 84:1006-1012, 1996
9. Date I, Shingo T, Ohmoto T, et al: Long-term enhanced chromaffin cell survival and behavioral recovery in hemiparkinsonian rats with co-grafted polymer-encapsulated human NGF-secreting cells. Exp Neurol 147:10-17, 1997
10. Date I, Shingo T, Yoshida H, et al: Grafting of encapsulated genetically modified cells secreting GDNF into the striatum of parkinsonian model rats. Cell Transplant 10:397-401, 2001
11. Deacon T, Schumacher J, Dinsmore J, et al: Histological evidence of fetal pig neural cell survival after transplantation into a patient with Parkinson's disease. Nat Med 3:350-353, 1997
12. Emerich DF, Frydel BR, Flanagan TR, et al: Transplantation of polymer encapsulated PC12 cells: use of chitosan as an immobilization matrix. Cell Transplant 2:241-249, 1993
13. Emerich DF, Winn SR, Hantraye PM, et al: Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease. Nature 386:395-399, 1997
14. Emerich DF, Winn SR, Lindner MD: Continued presence of intrastriatal but not intraventricular polymer-encapsulated PC12 cells is required for alleviation of behavioral deficits in parkinsonian rodents. Cell Transplant 5:589-596, 1996
15. Freed WJ, Patel-Vaidya U, Geller HM: Properties of PC12 pheochromocytoma cells transplanted to the adult rat brain. Exp Brain Res 63:557-566, 1986
16. Greene LA, Tischler AS: Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci USA 73:2424-2428, 1976
17. Hatton JD, Lechtman AN, U HS: Formation of PC12 tumors after transplantation into rat brains: dependence of time course on host age. Cancer Res 52:1933-1937, 1992
18. Hefti F, Hartikka J, Schlumpf M: Implantation of PC12 cells into the corpus striatum of rats with lesions of the dopaminergic nigrostriatal neurons. Brain Res 348:283-288, 1985
19. Jaeger CB: Immunocytochemical study of PC12 cells grafted to the brain of immature rats. Exp Brain Res 59:615-624, 1985
20. Jaeger CB, Aebischer P, Tresco PA, et al: Growth of tumor cell lines in polymer capsules: ultrastructure of encapsulated PC12 cells. J Neurocytol 21:469-480, 1992
21. Kim KT, Park DH, Joh TH: Parallel up-regulation of catecholamine biosynthetic enzymes by dexamethasone in PC12 cells. J Neurochem 60:946-951, 1993
22. Kordower JH, Palfi S, Chen EY, et al: Clinicopathological findings following intraventricular glial-derived neurotrophic factor treatment in a patient with Parkinson's disease. Ann Neurol 46: 419-424, 1999
23. Lindner MD, Plone MA, Mullins TD, et al: Somatic delivery of catecholamines in the striatum attenuate parkinsonian symptoms and widen the therapeutic window of oral sinemet in rats. Exp Neurol 145:130-140, 1997
24. Lindner MD, Winn SR, Baetge EE, et al: Implantation of encapsulated catecholamine and GDNF-producing cells in rats with unilateral dopamine depletions and parkinsonian symptoms. Exp Neurol 132:62-76, 1995
25. Ono T, Date I, Imaoka T, et al: Evaluation of intracerebral grafting of dopamine-secreting PC12 cells into allogeneic and xenogeneic brain. Cell Transplant 6:511-513, 1997
26. Saitoh Y, Eguchi Y, Hagihara Y, et al: Dose-dependent doxycycline-mediated adrenocorticotropic hormone secretion from encapsulated Tet-on proopiomelanocortin Neuro2A cells in the subarachnoid space. Hum Gene Ther 9:997-1002, 1998
27. Sautter J, Tseng JL, Braguglia D, et al: Implants of polymer-encapsulated genetically modified cells releasing glial cell line-derived neurotrophic factor improve survival, growth, and function of fetal dopaminergic grafts. Exp Neurol 149:230-236, 1998
28. Shingo T, Date I, Yoshida H, et al: Neuroprotective and restorative effects of intrastriatal grafting of encapsulated GDNF-producing cells in a rat model of Parkinson's disease. J Neurosci Res 69: 946-954, 2002
29. Shoji-Kasai Y, Yoshida A, Sato K, et al: Neurotransmitter release from synaptotagmin-deficient clonal variants of PC12 cells. Science 256:1821-1823, 1992
30. Simmons NE, Helm GA, Cail WS, et al: Magnetic resonance imaging of neuronal grafts in the primate. Exp Neurol 125:52-57, 1994
31. Subramanian T, Emerich DF, Bakay RAE, et al: Polymer-encapsulated PC-12 cells demonstrate high-affinity uptake of dopamine in vitro and 18F-DOPA uptake and metabolism after intracerebral implantation in nonhuman primates. Cell Transplant 6:469-477, 1997
32. Tohgi H, Abe T, Saheki M, et al: Concentration of catecholamines and indoleamines in the cerebrospinal fluid of patients with vascular parkinsonism compared to Parkinson's disease patients. J Neural Transm 104:441-449, 1997
33. Warren S, Chute RN: Pheochromocytoma. Cancer 29:327-331, 1972
34. Wilby MJ, Sinclair SR, Muir EM, et al: A glial cell line-derived neurotrophic factor-secreting clone of the Schwann cell line SCTM41 enhances survival and fiber outgrowth from embryonic nigral neurons grafted to the striatum and to the lesioned substantia nigra. J Neurosci 19:2301-2312, 1999
35. Winn SR, Hammang JP, Emerich DF, et al: Polymer-encapsulated cells genetically modified to secrete human nerve growth factor promote the survival of axotomized septal cholinergic neurons. Proc Natl Acad Sci USA 91:2324-2328, 1994